You are viewing: UK Empty Capsules Market analysis
Part of: Empty Capsules Market (Global)

The UK Empty Capsules Market was valued at $175.6 Million in 2025 and projected to reach to $233.7 Million by 2030, representing a compound annual growth rate of 5.9%. The UK empty capsules market is positioned for steady growth through 2030, driven by expanding pharmaceutical production, rising nutraceutical consumption, and regulatory support for advanced drug delivery systems.

UK Empty Capsules Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Empty Capsules Market Trends and Insights

  • The UK market benefits from strong pharmaceutical manufacturing infrastructure, increasing demand for nutraceutical products, and growing preference for capsule-based delivery systems among UK consumers and healthcare providers.
  • The UK's regulatory environment and established supply chains support sustained market expansion through the forecast period..

Key Market Statistics

  • CAGR (2025-2030) 5.9% CAGR
  • Market Size, 2025 ~USD 175.6 Million
  • Forecast, 2030 ~USD 233.7 Million
  • Country UK

UK Empty Capsules Market Overview

Market Valuation :

The UK empty capsules market is valued at $175.6 million in 2025, with projections reaching $233.7 million by 2030, representing a robust 5.9% CAGR specific to the UK market.

Pharmaceutical Manufacturing Strength :

The UK benefits from a well-established pharmaceutical manufacturing infrastructure with GMP-certified facilities, supporting consistent demand for high-quality empty capsules across domestic and export markets.

Nutraceutical Sector Growth :

Increasing consumer demand for dietary supplements and wellness products in the UK is driving adoption of capsule-based delivery systems, particularly among health-conscious demographics and aging populations.

Healthcare Provider Preference :

UK healthcare providers and pharmacists increasingly recommend capsule-based formulations due to improved bioavailability, patient compliance, and ease of administration compared to alternative delivery methods.

UK Empty Capsules Market Dynamics

  • The UK's strong healthcare infrastructure and consumer wellness awareness create favourable conditions for market expansion.
  • Additionally, increasing investments in contract manufacturing and the growing preference for personalised medicine are expected to boost capsule demand.
  • The market will likely benefit from innovation in capsule materials and manufacturing technologies, supporting both domestic consumption and export opportunities across European and international markets..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • The UK empty capsules market will grow from $175.6M (2025) to $233.7M (2030) at a 5.9% CAGR.
    • The UK market is driven by robust pharmaceutical manufacturing and rising nutraceutical demand.
    • The UK's regulatory framework and supply chain maturity provide competitive advantages.
    • The UK represents a significant European hub for capsule-based pharmaceutical and supplement production.

    Empty Capsules Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment SUSTAINED-RELEASE CAPSULES (Functionality)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.6% from 2025 to 2030
    Largest Segment IMMEDIATE-RELEASE CAPSULES (Functionality)
    Market Size Base Year (Billions) ~USD 3.19 (2025)
    Revenue Forecast (Billions) ~USD 4.19 (2030)
    Segments Covered Type, Raw Material, Functionality, Size, Therapeutic Application, End User

    UK Empty Capsules Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Gelatin Capsules
    • Non-Gelatin Capsules

    By Raw Material

    • Bonemeal Gelatin
    • Bovine-Derived Gelatin
    • Hydroxypropyl Methylcellulose (Hpmc)
    • Other Gelatin Sources
    • Porcine Gelatin
    • Pullulan & Starch

    By Functionality

    • Delayed-Release Capsules
    • Immediate-Release Capsules
    • Sustained-Release Capsules

    By Size

    • Size 0
    • Size 00
    • Size 000
    • Size 1
    • Size 2
    • Size 3
    • Size 4
    • Size 5

    By Therapeutic Application

    • Antacid & Antiflatulent Preparations
    • Anti-Inflammatory Drugs
    • Antianemic Preparations
    • Antibiotic & Antibacterial Drugs
    • Cardiovascular Therapy Drugs
    • Cough & Cold Drugs
    • Dietary Supplements
    • Other Therapeutic Applications

    By End User

    • Cosmetic Industry
    • Nutraceutical Industry
    • Pharmaceutical Industry
    • Research Laboratories

    UK: EMPTY CAPSULES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    COSMETIC INDUSTRY15.115.316.116.917.818.719.8215.5
    NUTRACEUTICAL INDUSTRY62.763.466.870.474.6798489.56
    PHARMACEUTICAL INDUSTRY80.18185.289.894.9100.5106.7113.55.9
    RESEARCH LABORATORIES7.27.27.67.98.38.79.29.75.1
    TOTAL165166.9175.6185195.5207219.8233.75.9

    Target Audience

    • Pharmaceutical Manufacturers : UK-based and international pharma companies require detailed market insights to optimise capsule sourcing, production planning, and supply chain strategies within the British market.
    • Nutraceutical & Supplement Producers : UK supplement manufacturers need market data to understand capsule demand trends, identify suppliers, and plan product development aligned with consumer preferences and regulatory requirements.
    • Contract Manufacturers & CMOs : Contract manufacturing organisations operating in the UK require market forecasts and competitive analysis to guide capacity investments, client acquisition, and service expansion strategies.
    • Capsule Suppliers & Distributors : UK-based and international capsule suppliers need market intelligence to identify growth opportunities, assess competitive positioning, and develop targeted sales strategies for the British market.
    • Healthcare & Investment Professionals : Investment firms, healthcare consultants, and business development teams require UK market data to evaluate investment opportunities, assess market viability, and support M&A activities in the sector.

    Key Companies in the UK Empty Capsules Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing, packaging, lifecycle management),Pharmaceutical development services (formulation, clinical trial supply),Drug substance services (API and biologics substance),
    ALLERGAN PLCIrelandPrivate CompanyMedical aesthetics and dermatology,Eye care,Neuroscience and CNS,
    HELM AGGermanyPrivate CompanyBasic Chemicals, Acids and Lyes,Plastics and Polyurethanes,Crop Protection and Fertilizers,
    SUNIL HEALTHCARE LIMITEDIndiaPublic CompanyStandard empty hard gelatin capsules (incl. BSE/TSE free, pearl, natural color),Functional and specialty capsules (liquid-fill, preservative-free, stick-free, flavored, SLS-free, non-AZO),HPMC/vegetable capsules,
    NATURAL CAPSULES LIMITEDIndiaPublic CompanyStandard hard gelatin capsule shells,Vegetarian and cellulose-based capsule shells,Enteric, fast-release, and functional capsules,
    ANHUI HUANGSHAN CAPSULE CO., LTD.ChinaPublic CompanyVacant gelatin capsules (standard),Enteric-coated / entersoluble gelatin capsules,Vegetable capsules (HPMC, pullulan, vegetable entersoluble),

    PATHEON INC

    Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and contract manufacturing sector.

    ALLERGAN PLC

    Allergan PLC is an Ireland-incorporated private company founded in 1983 with 17,400 employees, operating in the pharmaceutical and specialty healthcare industry.

    HELM AG

    Helm AG is a Germany-based private company founded in 1900 with 1,430 employees, operating in the pharmaceutical and chemical distribution industry.

    SUNIL HEALTHCARE LIMITED

    Sunil Healthcare Limited is an India-based public company founded in 1973 with 161 employees operating in the pharmaceutical sector.

    NATURAL CAPSULES LIMITED

    Natural Capsules Limited is an India-based public company founded in 1993 with 615 employees operating in the pharmaceutical capsule manufacturing industry.

    ANHUI HUANGSHAN CAPSULE CO., LTD.

    Anhui Huangshan Capsule Co., Ltd. is a China-based public company founded in 1989 with 639 employees operating in the pharmaceutical capsule manufacturing industry.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Access precise valuation data for the UK market ($175.6M in 2025) with detailed forecasts through 2030, enabling accurate budgeting and investment decisions tailored to the British market landscape.
    • Competitive Intelligence : Identify key UK manufacturers, suppliers, and market players with insights into their market positioning, capacity utilisation, and strategic initiatives specific to the British pharmaceutical and nutraceutical sectors.
    • Regulatory & Compliance Insights : Understand UK-specific regulatory requirements, GMP standards, and compliance frameworks governing empty capsule production and distribution, ensuring market-entry strategies align with local regulations.
    • Growth Driver Analysis : Analyse UK-specific demand drivers including pharmaceutical manufacturing trends, consumer wellness preferences, and healthcare provider adoption patterns to identify high-potential market segments and opportunities.
    • Strategic Market Planning : Develop informed go-to-market strategies, pricing models, and distribution approaches based on comprehensive UK market dynamics, consumer behaviour, and competitive landscape data.

    Frequently asked questions

    What is the current size of the UK empty capsules market?

    The UK empty capsules market is estimated at $175.6 million in 2025.

    What is the projected size of the UK empty capsules market by 2030?

    The UK empty capsules market is forecast to reach $233.7 million by 2030.

    What is the growth rate of the UK empty capsules market?

    The UK empty capsules market is expected to grow at a CAGR of 5.9% from 2025 to 2030.

    What factors are driving growth in the UK empty capsules market?

    Key drivers include strong pharmaceutical manufacturing capabilities, increasing nutraceutical demand, and consumer preference for capsule-based delivery systems in the UK.

    Why is the UK important for the empty capsules market?

    The UK has established regulatory frameworks, mature supply chains, and significant pharmaceutical manufacturing infrastructure that support the empty capsules market.

    RESEARCH METHODOLOGY

    This research extensively utilized secondary sources, directories, and databases to gather valuable information for analyzing the global empty capsules market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Empty capsules market. The secondary sources used for this study includes European Federation of Pharmaceutical Industries and Associations (EFPIA), United States Food and Drug Administration (US FDA), Central Drugs Standard Control Organisation (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), National Institutes of Health (NIH), World Health Organization (WHO), among others. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After an initial assessment of the global empty capsules market landscape through secondary research, comprehensive primary research was conducted. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from the pharmaceutical, nutraceutical, and cosmetic industries, as well as research laboratories. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from leading empty capsules manufacturers, distributors, and channel partners. The research covered six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. About 70% of the primary interviews were with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and phone discussions to thoroughly understand market dynamics.

    The following is a breakdown of the primary respondents:

    Empty Capsules Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both bottom-up and top-down approaches were used to estimate and validate the total size of the empty capsules market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    A list of the major global players operating in the empty capsules market was generated.

    The revenues generated from their empty capsules product have been determined through annual reports and secondary sources (including paid databases)

    The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.

    The combined revenue share of the players was estimated and then added up to 100% to derive the global empty capsules market.

    All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

    Global Empty Capsules Market Size: Bottom-up and Top-down Approach

    Empty Capsules Market

    Data Triangulation

    After determining the market size through the estimation process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used whenever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

    Market Definition

    A capsule is a form of solid oral dosage that consists of a container, usually made of gelatin or HPMC material, filled with a medicinal substance. Empty capsules are hard shells of various shapes, typically designed to hold a single dose of active ingredients. At the time of sale, these capsules are not filled with any pharmaceutical or nutraceutical ingredients. They are made in two halves: a smaller-diameter “body” that is filled and sealed with a larger-diameter “cap”.

    Stakeholders

    • Empty Capsules Manufacturing Companies
    • Pharmaceutical Companies
    • Nutraceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Manufacturing Organizations (CMOs)
    • Research Laboratories & Academic Institutes.
    • Market Research & Consulting Firms
    • Regulatory Bodies

    Report Objectives

    • To define, describe, and forecast the empty capsules market based on type, raw material, functionality, size, therapeutic application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the empty capsules market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global Empty capsules market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the empty capsules market
    • To benchmark players within the empty capsules market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business strategies and product footprints.

    Get the Full Empty Capsules Market Report

    Full forecast, segment splits, and company analysis for all Empty Capsules Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status